Baudax Bio, Inc.
BXRXQ · OTC
9/30/2023 | 6/30/2023 | 3/31/2023 | 12/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,891 | -$7,301 | -$7,386 | -$9,250 |
| Dep. & Amort. | $131 | $1 | $3 | $105 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $253 | $198 | $191 | $229 |
| Change in WC | $2,944 | $654 | $777 | -$594 |
| Other Non-Cash | -$3,850 | $3,002 | $1,751 | $5,727 |
| Operating Cash Flow | -$2,413 | -$3,446 | -$4,664 | -$3,783 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$21 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | -$21 | $0 | $0 | $0 |
| Investing Cash Flow | -$21 | $142 | $0 | $0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$550 | -$2,400 | -$1,100 | -$1,132 |
| Stock Issued | $1,712 | $3,494 | $4,328 | $4,367 |
| Stock Repurch. | $0 | $0 | -$15 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $219 | -$192 | $4,323 | $160 |
| Financing Cash Flow | $1,381 | $917 | $3,208 | $3,395 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$1,053 | -$2,387 | -$1,456 | -$388 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,416 | $3,803 | $5,259 | $5,647 |
| End Cash | $363 | $1,416 | $3,803 | $5,259 |
| Free Cash Flow | -$2,434 | -$3,446 | -$4,664 | -$3,783 |